PharmD Degree Program

School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

USP/UCSF fellowship to support research in the quality and safety of medical products

A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.

Medical and pharmacy students jointly tackle health care’s most pressing dilemmas

A two-week course brought first-year UCSF medical and pharmacy students together, for the first time, to grapple with controversies and challenges in health care using scientific evidence and faculty-led discussion.

Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean

The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.

Creating an inexhaustible database for drug molecules

School of Pharmacy researchers helped a free public database of potential drug molecules grow 100-fold.

QBI fellowship fosters curiosity and perseverance for women scientists

Jacqueline Kyosiimire-Lugemwa, the first recipient of QBI’s Scholarship for Women from Developing Nations in Biosciences, spent a year at UCSF in which her perseverance in the sciences was tested. She recently returned to her home country of Uganda more ready than ever to tackle big questions about...

CRISPR-based obesity treatment shows promise for other diseases

A recent study by Nadav Ahituv, PhD, showed that obesity caused by a gene mutation could be treated in animal models.

Fraser appointed to Bowes Biomedical Investigator Program

Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.

Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.

Combination drug therapy overcomes drug-resistant lung cancer in the lab

Many types of lung cancer thwart even the most targeted of therapies due to drug resistance, but a group of UCSF scientists led by Sourav Bandyopadhyay, PhD, have now shown that adding a second drug into treatment regimens can overcome this resistance in lab-grown, lung cancer cell lines.

Pages